All
  • All
  • Product Management
  • News
  • Introduction
  • Enterprise outlets
  • FAQ
  • Enterprise Video
  • Enterprise Atlas
Search

Chinese

  • Home

  • About Livzon

    • Chairman's Speech

    • Milestones

    • Leaders' Caring

    • Company Honors

    • Cultural Vision

    • Contact Us

  • Media

    • Livzon News

    • Employment system

  • Investor Relations

    • Company Governance

    • Announcement

    • Financial Reports

    • ESG Report

    • Shareholder Returns

    • Stock Information

    • Investor Relations

  • Sustainable Development

    • ESG Report

    • Human Development

    • Board Diversity Policy

    • Business Ethics

    • Supplier

    • Environment, Occupational Health and Safety (EHS)

    • Philanthropy

    • Privacy Policy

    • Tax policy

    • ESG Ratings and Honors

  • Product

    • Leading Products

    • Products List

    • ADR Reporting

  • R&D

    • R&D Platforms

    • Livzon microspheres

    • Livzon Bio

    • Livzon Research Institute

    • R&D Achievements

    • IP Achievements

  • Overseas Market

    • Overseas Business

    • Specialty Products

    • Certificates

    • Contact us

  • Join Us

    • Social Recruitment

    • Campus Recruitment

    • Compensation and Benefits

    • Contact Us

    • Appeal Against

  • Bidding procurement

    • Tender Announcement

    • Supplier Login

    • Supervision and Reporting

  • Contact Us

    • Contact information

    • Online message

中文版 ENGLISH
Contact Us
  • Home page
Products News Center
Bismuth Potassium Citrate Tablets

Bismuth Potassium Citrate Tablets


Key words:

LIVZON

Antiviral Granules

Antiviral Granules


Key words:

LIVZON

Cetrorelix Acetate for Injection

Cetrorelix Acetate for Injection


Key words:

LIVZON

Tocilizumab Injection

Tocilizumab Injection


Key words:

LIVZON

Latest Products

Bismuth Potassium Citrate Tablets

Antiviral Granules

Cetrorelix Acetate for Injection

Tocilizumab Injection

Recombinant Human Choriogonadotropin alfa for Injection

the Recombinant SARS-COV-2 Fusion Protein Vaccine LIKANG V-01

Active pharmaceutical ingredients

Active pharmaceutical ingredients

Active pharmaceutical ingredients

Quality supervisor

Latest News

The new generation of high-efficiency acid-inhibiting agent injection JP-1366 by Livzon has been approved for clinical use.

Good news frequently arrives | Livzon Group's clinical trial application for injectable JP-1366 has been accepted by the National Medical Products Administration's Drug Evaluation Center.

Research and innovation also speed up the progress bar | Livzon Group JP-1366 Phase III clinical study launched

Livzon Group's Semaglutide Injection has completed the enrollment of all cases in the Phase III clinical trial for weight management indications.

Livzon and Neosun jointly announced: The Phase I clinical trial of KCNQ2/3 activator (NS-041) has been successfully completed.

Once again on the list! Livzon Group has been selected as one of the "Top 100 ESG Best Practices of Chinese Listed Companies in 2024" by Wind.

Address: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China   

京ICP备10002622号

Website :www.300.cn SEO  [ Privacy Policy ] 

Internet Drug Information Service Qualification Certificate: Guangdong-Non-Operating -2020-0186

Drug Business License: Guangdong AA7560155

Business License

Home | E-mail | Legal Statement

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

%E7%AC%AC%E4%B8%80%EF%BC%8C%E6%9C%80%EF%BC%8C%E4%BC%98%E7%A7%80%EF%BC%8C%E5%A2%9E%E5%BC%BA%EF%BC%8C%E4%B8%80%E6%B5%81%EF%BC%8C%E5%8D%93%E8%B6%8A%EF%BC%8C%E9%A2%86%E5%85%88%EF%BC%8C%E5%85%88%E8%BF%9B%EF%BC%8C%E5%BC%95%E9%A2%86

Sorry,当前栏目暂无内容!

您可以查看其他栏目或返回 首页

Sorry,The current column has no content!

You can view other columns or return Home